The LLS Blog
Read about survivors, research, fundraising and advocacy.
FDA Approves New Maintenance Treatment for AML
Posted On: September 02, 2020
Some promising news to kick off Blood Cancer Awareness Month – on September 1, 2020, the U.S. Food and Drug Administration approved a new oral maintenance treatment for certain adult patients with acute myeloid leukemia (AML).
An Emerging Target for Myeloma Therapy Could Prove a Game-Changer
Posted On: August 06, 2020
When the Insurance Says No to a Clinical Trial
Posted On: August 04, 2020
As an LLS Clinical Trial Nurse Navigator, Ashley Giacobbi works tirelessly to connect the right patient with the right clinical trial – work that has become increasingly complicated in the COVID-19 era. But recently, she went the extra mile to ensure a patient – a young healthcare worker whose AML had relapsed several times – could access a trial that offered a promising treatment option.
A New CAR-T Approval Brings Hope for Mantle Cell Lymphoma Patients
Posted On: July 24, 2020
On Pride Day, LGBTQI+ Cancer Survivors Share Their Stories
Posted On: July 01, 2020